Preview

Epidemiology and Vaccinal Prevention

Advanced search

Features of the COVID-19 Epidemic Process in Each of the of the Five Waves of Morbidity in Russia

https://doi.org/10.31631/2073-3046-2023-22-2-23-36

Abstract

Aim. To assess the intensity of the epidemic process in each of the five waves of COVID-19 in Russia.

Materials and methods. The data on morbidity, hospitalization and deaths from COVID-19 of the population as a whole and by age groups from 48 (in the I rise) to 54 cities (in the V wave) and data from the website of the Russian consortium for sequencing coronavirus genomes were analyzed.

Results. The nature of the course of the first 5 waves in the incidence of COVID-19 in Russia remains undulating. The waves in morbidity began in megacities, and the direction of spread across the FD differed in different waves of morbidity. The results of gene sequencing showed the participation of the main genovariants of the coronavirus in the etiology of diseases up to 3-4 waves. Some genovariants identified earlier received maximum distribution in the following wave. In Russia, the European descendants of the Wuhan strain (74.4%) were dominant in the I wave in morbidity, in the II wave – its daughter genovariants (68.5%), in the III – AY.122 (80.1%), in the IV – AY.122 (84.7%) and in the V wave – Omicron (76.7%).

Conclusions. The features of each wave in the incidence of COVID-19 depended on the properties of the dominant genovariants: their ability to transmit from person to person and virulence. The rate of spread of the epidemic by FD, the susceptibility of all age groups and the intensity of epidemics were maximal during the period of the V wave in morbidity with the Omicron gene variant. Mortality was minimal in the I wave of morbidity, maximal in the IV with AY.122 strains and low in the V wave with Omicron genovariants. The influence of the season of the year was manifested in the summer season by an increase in the incidence of COVID-19 earlier in the Russian Federation as a whole (immediately after megacities) than in most federal districts, but with a lower incidence.

About the Authors

L. S. Karpova
The Federal State Budgetary Institution «Smorodintsev Research Influenza Institute» of Ministry of Healthcare of the Russian Federation
Russian Federation

Karpova Ludmila S. - Dr. Sci. (Med.), senior researcher, head of laboratory.

15/17, prof. Popov street, Saint-Petersburg, 197376,  +7 (812) 499-15-33



A. B. Komissarov
The Federal State Budgetary Institution «Smorodintsev Research Influenza Institute» of Ministry of Healthcare of the Russian Federation
Russian Federation

Andrey B. Komissarov – head of laboratory.

Saint-Petersburg,+7  (812) 499-15-20



K. A. Stolyarov
The Federal State Budgetary Institution «Smorodintsev Research Influenza Institute» of Ministry of Healthcare of the Russian Federation
Russian Federation

Kirill A. Stolyarov – lead programmer.

Saint-Petersburg, +7 (911) 218-32-43



N. M. Popovtseva
The Federal State Budgetary Institution «Smorodintsev Research Influenza Institute» of Ministry of Healthcare of the Russian Federation
Russian Federation

Nina M. Popovtseva – technician.

Saint-Petersburg,+7 (812) 499-15-32



T. P. Stolyarova
The Federal State Budgetary Institution «Smorodintsev Research Influenza Institute» of Ministry of Healthcare of the Russian Federation
Russian Federation

Tatyana P. Stolyarova – technician.

Saint-Petersburg,+7 (812) 499-15-32



M. Yu. Pelikh
The Federal State Budgetary Institution «Smorodintsev Research Influenza Institute» of Ministry of Healthcare of the Russian Federation
Russian Federation

Maria Yu. Pelikh  – Researcher.

Saint-Petersburg,+7 (812) 499-15-32



D. A. Lioznov
The Federal State Budgetary Institution «Smorodintsev Research Influenza Institute» of Ministry of Healthcare of the Russian Federation; First Pavlov State Medical University
Russian Federation

Dmitry A. Lioznov – director of the Federal State Budgetary Institution Smorodintsev Research Influenza Institute.

Saint-Petersburg, +7 (812) 499-15-00



References

1. Bolze A., Luo Sh., White S., Cirulli E., et al. SARS-CoV-2 Variant Delta Rapidly Displaced Variant Alpha in the United States and Led to Higher Viral Loads. Cell Reports Medicine 3, 100564, March 15, 2022

2. World Health Organization. Statement on Omicron sublineage BA.2 https://www.who.int/news/item/22-02-2022-statement-on-omicron-sublineage-ba.2

3. ECDC 2022. Situation updates on COVID-19. Variants of concern. Available at: https://www.ecdc.europa.eu/en/covid-19/variants-concern

4. Starodubov V.I., Beregovykh V.V., Akimkin V.G., et al. COVID-19 in Russia: Evolution of Views on the Pandemic. Report I // Annals of the Russian academy of medical sciences. - 2022. - Vol. 77. - N. 3. - P. 199–207. doi: 10.15690/vramn2118

5. Karpova L.S., Stolyarov K.A., Popovtseva N.M., et al. Stolyarova T.P., Danilenko D.M. Comparison of the First Three Waves of the COVID-19 Pandemic in Russia in 2020–21. Epidemiology and Vaccinal Prevention. 2022;21(2):4–16. (In Russ.) https://doi.org/10.31631/2073-3046-2022-21-2-4-16

6. Stopkoronavirus.rf, available at: https://стопкоронавирус.рф

7. Knorre D.D., Nabieva E., Garushyants S.K. Russian Consortium for Genome Sequencing of Coronaviruses (CORGI), Bazykin G.A. taxameter.ru. http://taxameter.ru / (2021) https://corgi.center/

8. Akimkin V.G., Popova A.Yu., Ploskireva A.A., et al. COVID-19: the evolution of the pandemic in Russia. Report I: manifestations of the COVID-19 epidemic process. Journal of microbiology, epidemiology and immunobiology = Zhurnal mikrobiologii, èpidemiologii i immunobiologii.2022;99(3):269–286. DOI: https://doi.org/10.36233/0372-9311-276

9. Danilenko D.M., Komissarov A.B., Stukova M.A., Lioznov D.A. To be or not to be: forecast of Covid-19 epidemic development in Russia. Journal Infectology. 2020;12(3):6–11. (In Russ.) https://doi.org/10.22625/2072-6732-2020-12-3-6-11

10. Klink GV, Safina KR, Nabieva E, et al. The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia. Virus Evol. 2022 Mar 5;8(1): veac017. doi: 10.1093/ve/veac017. PMID: 35371558; PMCID: PMC8966696.

11. Klink GV, Safina KR, Garushyants SK, et al. CoRGI (Coronavirus Russian Genetic Initiative) Consortium. Spread of endemic SARS-CoV-2 lineages in Russia before April 2021. PLoS One. 2022 Jul 20;17(7):e0270717. doi: 10.1371/journal.pone.0270717. PMID: 35857745; PMCID: PMC9299347.

12. Borisova N.I., Kotov I.A., Kolesnikov A.A., et al. Monitoring of the spread of variants of SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus; Sarbocovirus) in the Moscow region using targeted hign-performance sequencing. Questions of virology. 2021;66(4):269–278 (In Russ.).

13. Zaitseva N.N., Polyanina A.V., Novikova N.A., et alEpidemiological monitoring of the circulation of genetic variants of the SARS-COV-2 virus on the territory of the Volga Federal District. Proceedings of the XIV Annual All-Russian Congress on Infectious Diseases named after Academician V.I. Pokrovsky, Moscow, March 28-30, 2022. Infectious diseases in the modern world: evolution, current and future threats. M. Med. marketing Agency. 2022. p. 63.

14. Burtseva E.I., Kolobukhina L.V., Voronina O.L., et al. Features of the circulation of ARVI pathogens against the background of the appearance and widespread spread of SARS-CoV-2 in the period 2018–2021. Epidemiology and Vaccination Prevention. 2022;21(4):16–26 (In Russ.). https://doi.org/10.31631/2073-3046-2022-21-4-16-26

15. Akimkin V.G., Popova A.Yu., Khafizov K.F., et al. COVID-19: evolution of the pandemic in Russia. Report II: dynamics of the circulation of SARS-CoV-2 genetic variants. Journal of microbiology, epidemiology and immunobiology = Zhurnal mikrobiologii, èpidemiologii i immunobiologii. 2022;99(4):381–396 (In Russ.). DOI: https://doi.org/10.36233/0372-9311-295

16. Sominina A.A., Danilenko D.M., Stolyarov K.A., et al. Interference of SARS–CoV–2 with other Respiratory Viral Infections agents during Pandemic. Epidemiology and Vaccinal Prevention. 2021;20(4):28– 39. (In Russ.) https://doi.org/10.31631/2073–3046–2021–20–4–28–39

17. Slis’ S.S., Kovalev E.V., Yanovich E.G., et al. The Main Risks of an Еpidemic Emergency Associated with New Respiratory Viruses. Epidemiology and Vaccinal Prevention. 2022;21(2):74–82 (In Russ.) https://doi.org/10.31631/2073-3046-2022-21-2-74-82

18. Bashketova N.S., Fridman R.K., Kataeva I.S., et al. Analysis of the prevalence and structure of asymptomatic SARS-CoV-2 carrier among adolescents and adults during the epidemic rise in the incidence of COVID-19 in January 2022. Epidemiology and infectious diseases. 2022;12(1):11–17 (In Russ.)

19. Ilyinskikh E.N., Reshetova A.V., Rudikov A.A., et al. Structure and dynamics of the incidence of a new coronavirus infection COVID-19 of the population of the Tomsk region in 2021. Proceedings of the VIII Congress of the Euro-Asian Congress on May 17–18, 2022. Journal of Infectology 2022;14(2):48. (In Russ.)

20. Kravchenko NA, Kazanova VB, Khakimova MI, et al. Dynamics of Morbidity and Etiological Structure of Acute Respiratory Infections on the Eve and in the First Year of COVID-19 in the Irkutsk Region. Epidemiology and Vaccinal Prevention. 2022;21(3):50–62 (In Russ.). https://doi:10.31631/2073-3046-2022-21-3-50-62


Review

For citations:


Karpova L.S., Komissarov A.B., Stolyarov K.A., Popovtseva N.M., Stolyarova T.P., Pelikh M.Yu., Lioznov D.A. Features of the COVID-19 Epidemic Process in Each of the of the Five Waves of Morbidity in Russia. Epidemiology and Vaccinal Prevention. 2023;22(2):23-36. (In Russ.) https://doi.org/10.31631/2073-3046-2023-22-2-23-36

Views: 1167


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-3046 (Print)
ISSN 2619-0494 (Online)